Mannatech (NASDAQ:MTEX) Now Covered by StockNews.com

StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Tuesday. The firm issued a buy rating on the stock.

Mannatech Stock Down 0.3 %

NASDAQ MTEX opened at $7.86 on Tuesday. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. Mannatech has a 52 week low of $6.75 and a 52 week high of $10.51. The business’s fifty day simple moving average is $7.84 and its 200-day simple moving average is $7.56. The firm has a market cap of $14.82 million, a PE ratio of -9.70 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last posted its earnings results on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. The firm had revenue of $31.73 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.

Insider Transactions at Mannatech

In other news, Director Larry A. Jobe sold 16,288 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the sale, the director now directly owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. The trade was a 22.94 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 41.50% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.